Sixty-six healthy adults with ( 25 ( OH ) D ) < 33 ng/mL were randomly assigned to take one of three D3 supplements , ie , a chewable tablet ( TAB ) , an oil-emulsified drop ( DROP ) , or an encapsulated powder ( CAP ) at a label-claimed dose of 10,000 IU/day .